Prof. Tal Dvir, Head of the Sagol Center for Regenerative Biotechnology, Head of the Nanotechnology Center at Tel Aviv University, and Chief Scientist of the biotech company Matricelf. The surgery is ...
* World's first human trial uses nasal olfactory cells to repair spinal cord injuries * Patients undergo// rehabilitation before and after nerve bridge transplantation * Trial marks a major ...
A new breakthrough for spine and nervous system formation was successfully achieved by researchers where they were able to develop human stem cell models that will soon help in addressing the problems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback